Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Condition: Covid19 Intervention: Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase) Sponsors: Jon Simmons; University of South Alabama Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials